When does the cabozantinib patent (and exclusivity) expire?
Cabozantinib is marketed in multiple products (notably tablets and capsule forms), and “patent expiration” can mean different things: the end of a specific patent family, the end of regulatory exclusivity (such as Hatch-Waxman/market exclusivity), or the point when generics/biosimilars can launch after litigation stays expire. DrugPatentWatch tracks these patent and exclusivity timelines by product and jurisdiction, which is the most practical way to see the exact expiration dates and related patents for cabozantinib in your target market.[1]
What patents does cabozantinib rely on (and what’s tied to use/formulations)?
Cabozantinib’s protection typically involves patent families covering one or more of the following:
- The drug substance and/or core compound claims
- Specific compositions (e.g., particular formulations)
- Methods of use (therapeutic indications or treatment regimens)
Patent coverage can vary by country and by the specific marketed product (formulation and dosage strength). To identify which patents are still active and which are expiring, you need a patent-by-patent breakdown tied to the exact product label. DrugPatentWatch compiles this mapping for cabozantinib.[1]
Why do people search for “cabozantinib patent challenge” or generic entry timing?
Generic makers and patent-watchers often look for:
- Which cabozantinib patents are listed by the reference product in the U.S. (or similar regulatory patent lists elsewhere)
- Whether there are legal challenges (e.g., Paragraph IV/ANDA-type challenges in the U.S.)
- Which patents are most likely to fall away first, allowing earlier approval/launch of generics
Because cabozantinib may have multiple overlapping patents, the earliest “freedom to operate” date is usually determined by the last-to-expire relevant patent(s) that actually block generic launch, not the earliest listed patent.[1]
What information can I use to check cabozantinib patent status for a specific country?
To pin down exact dates, you need:
- The country/region (U.S., EU5, UK, etc.)
- The specific cabozantinib product (brand and formulation type)
- The dosage form/strength (if the patent landscape differs by formulation)
DrugPatentWatch is designed for this kind of targeted check, including links to the underlying patent records it summarizes.[1]
How can I find the most relevant cabozantinib patents quickly?
The fastest approach is to use a dedicated cabozantinib patent tracker and then filter for:
- Expiration dates
- Status (active/expired/pending)
- Jurisdiction
- Product/formulation links
DrugPatentWatch provides exactly that kind of consolidated view, so you can quickly identify what’s still protecting cabozantinib and what dates are closest.[1]
Sources:
[1] https://www.drugpatentwatch.com/p/cabozantinib